Menon, Venu, Rumsfeld, John S., Roe, Matthew T., Cohen, Mauricio G., Peterson, Eric D., Brindis, Ralph G., Chen, Anita Y., Pollack, Charles V., Smith, Sidney C., Gibler, W. Brian, and Ohman, E. Magnus
To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.amjmed.2006.01.018 Byline: Venu Menon (a), John S. Rumsfeld (b), Matthew T. Roe (c), Mauricio G. Cohen (d), Eric D. Peterson (c), Ralph G. Brindis (e), Anita Y. Chen (c), Charles V. Pollack (f), Sidney C. Smith (d), W. Brian Gibler (g), E. Magnus Ohman (c) Keywords: Acute coronary syndromes; Non-ST elevation myocardial infarction; Outcomes; Regional variation Abstract: An analysis of reginal variation across the United States in the treatment and outcomes of patients with non-ST-segment elevation acute coronary syndromes (NSTE ACS) has not been previously performed. Author Affiliation: (a) Department of Cardiology, Cleveland Clinic Foundation, Cleveland, Ohio (b) Section of Cardiology, Denver VA Medical Center, Denver, Colo (c) Division of Cardiology and Duke Clinical Research Institute, Duke University Medical Center, Durham, NC (d) Division of Cardiology, University of North Carolina School of Medicine, Chapel Hill, NC (e) Oakland Kaiser Permanente Hospital, San Francisco, Calif (f) Department of Emergency Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pa (g) Department of Emergency Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio Article Note: (footnote) CRUSADE is a National Quality Improvement Initiative of the Duke Clinical Research Institute. CRUSADE is funded by Millennium Pharmaceuticals, Inc. (Cambridge, Mass) and Schering Corporation (Kenilworth, NJ). Bristol-Myers Squibb (Plainsboro, NJ)/Sanofi Pharmaceuticals (New York, NY) Partnership provides additional funding support.